Skip to main content
. 2020 May 27;40(5):BSR20200008. doi: 10.1042/BSR20200008

Figure 3. The survival analysis of CD37 in patients with AML.

Figure 3

(A,B) The survival curves of OS in AML patients with regard to CD37 expression by GEPIA and UALCAN, respectively. (C,D) The OS and DFS of patients with AML categorized by CD37 median expression. (E,F) According to CD37 Z-score, the OS and DFS of patients without APL.